The organs are then transplanted to patients who are suffering heart failure, or are in endstage lung
They will then be transplanted into patients suffering heart failure or endstage lung
disease, as defined morphologically, represents the culmination of a "dying-back" process of acini within the secondary pulmonary lobule.
For example, Porter and Paleologos reported the successful use of this strategy in a patient with endstage lung
disease secondary to cystic fibrosis who required a percutaneous endoscopic gastrostomy (4).